Fuller & Thaler Asset Management
BSTG

Fuller & Thaler Asset Management’s Biostage, Inc. Common Stock BSTG Stock Holding History

Fuller & Thaler Asset Management’s Portfolio BSTG Stock Details BSTG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-90,500
Closed -$430K – 769
2013
Q4 		$430K Buy
+90,500
New +$423K 0.02% 316

Other funds holding BSTG

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAIM
Punch & Associates Investment Management Edina, Minnesota $1.73B AUM 27.65% 1-Year Est. Return
HSA
Hussman Strategic Advisors Ellicott City, Maryland $463M AUM 16% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return

Fuller & Thaler Asset Management's BSTG Position: Q1 2014 in Review

Fuller & Thaler Asset Management sold out of Biostage, Inc. Common Stock (BSTG) in Q1 2014, closing a stake of 90,500 shares — an estimated $430K sold.

Fuller & Thaler Asset Management first reported a position in BSTG in Q4 2013 and held it in 1 quarter. The position peaked at $430K in Q4 2013. 51 funds tracked by Wall St. Rank hold BSTG as of Q1 2014.

  • Fuller & Thaler Asset Management reported no remaining Biostage, Inc. Common Stock position as of Q1 2014 after selling out during the quarter.
  • Fuller & Thaler Asset Management sold 90,500 Biostage, Inc. Common Stock shares in Q1 2014, an estimated $430K.
  • Fuller & Thaler Asset Management first reported a position in Biostage, Inc. Common Stock in Q4 2013 and held it in 1 quarter.
  • Fuller & Thaler Asset Management's Biostage, Inc. Common Stock position peaked at $430K in Q4 2013.
  • 51 funds tracked by Wall St. Rank held Biostage, Inc. Common Stock as of Q1 2014.

Based on Fuller & Thaler Asset Management's 13F filing for Q1 2014, filed 13 May 2014.